title: [The efficacy of leukinferon in suppurative-septic diseases].
abstract: In the complex of treatment of purulent-septic diseases leukinferon at a dose of 300 IU/kg was used according to the following scheme: 3 injections with the 48 h interval between injections. The effect of leukinferon mainly on the function of neutrophil granulocytes and subpopulation of T-lymphocytes was established. Together with clinico-laboratory data indicative of the effectiveness of treatment, normalization of interferon status and decrease in the level of a circulating factor of tumour necrosis in seriously ill patients was observed.
authors: N Ia
authors: NIa
authors: Spivak
authors: L A
authors: LA
authors: Ganova
authors: L F
authors: LF
authors: Iakovenko
authors: B A
authors: BA
authors: Kravchuk
authors: A V
authors: AV
authors: Makarov
authors: L D
authors: LD
authors: Krivokhatskaia
authors: A A
authors: AA
authors: Simonova
authors: S M
authors: SM
authors: Belotskiĭ
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016207:Cytokines / Q000627:therapeutic use*; D004338:Drug Combinations; D005490:Focal Infection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D018805:Sepsis / Q000276:immunology / Q000628:therapy*; D014946:Wound Infection / Q000276:immunology / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D004338:Drug Combinations; D007370:Interferon Type I; C062252:leukinferon
vernacular_title: Effektivnost' leĭkinferona pri gnoĭno-septicheskikh zabolevaniiakh.